JPSCR Journal of Pharmaceutical Science and Clinical Research

JPSCR宣布了一项关于规范人工智能（AI）使用的新编辑政策：作者须确保AI生成内容不超过20%，并须在参考文献列表前附上AI使用声明。 模型中文摘要

JPSCR announces a new editorial policy regulating the use of Artificial Intelligence (AI). Authors are required to ensure that AI-generated content does not exceed 20%. Authors must also include a Declaration of AI Use before the References list.

作者身份应仅限于对研究的构思、设计、执行或解释做出重大贡献的人员，所有做出重大贡献者均应列为共同作者；参与研究某些实质方面的人员应在致谢中说明或列为贡献者；通讯作者须确保论文包含所有适当的共同作者、不包含不当的共同作者，且所有共同作者已阅读并批准论文最终版本。 模型中文摘要

Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The …

未经作者明确书面同意，编辑不得将投稿稿件中披露的未发表材料用于自己的研究。 模型中文摘要

Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.

作者应向编辑部提供与论文相关的原始数据以供编辑审查，并应在可行时准备公开这些数据（符合ALPSP-STM关于数据和数据库的声明），无论如何都应在论文发表后合理时间内保存这些数据。 模型中文摘要

Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

该期刊是由 UNS 药学系出版的同行评审期刊，其出版伦理声明基于 COPE 编辑最佳实践指南，明确了作者、主编、编委会、同行评审者和出版商等所有参与方的伦理行为。 模型中文摘要

Journal of Pharmaceutical Science and Clinical Research (e-ISSN 2503-331x) is a peer-reviewed journal published by Department of Phamacy, Faculty of Mathematics and Natural Sciences, Universitas Sebelas Maret. This statement clarifies the ethical behavior of all parties involved in the act of publishing an article in this journal, including the author, the chief editor, the Editorial Board, the pe…

在 JPSCR 发表的作者保留版权，并授予期刊首次出版权，作品同时以知识共享署名-相同方式共享 4.0 许可证授权；作者还可就期刊出版版本的非排他性分发签订额外的单独协议（如存入机构库或出版成书），但须注明作品在本期刊的首次发表。 模型中文摘要

An author who publishes in the Journal of Pharmaceutical Science and Clinical Research (JPSCR) agrees to the following terms: Author retains the copyright and grants the the journal the right of first publication of the work simultaneously licensed under the Creative Commons Attribution-ShareAlike 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and …

该期刊遵循让公众自由获取研究以促进更大范围全球知识交流的原则，对其内容提供即时开放获取。 模型中文摘要

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

JPSCR 是由 UNS 药学系与印度尼西亚药剂师协会（IAI）梭罗市分会联合出版的开放获取同行评审期刊；投稿的研究文章将接受至少2名审稿人的双盲同行评审，最终录用决定由编辑根据审稿人意见作出，录用的研究文章将在线发布。 模型中文摘要

JPSCR is an open access and peer-reviewed journal published by Pharmacy Department, Universitas Sebelas Maret, jointly with Ikatan Apoteker Indonesia (IAI) Pengurus Cabang Kota Surakarta. The research article submitted to this online journal will be peer-reviewed (double-blind review process) at least 2 (two) reviewers. The final decision of articles acceptance will be made by Editors according to…

为确保文章不含抄袭，JPSCR 使用 Turnitin.com 的查重软件。 模型中文摘要

To ensure that the articles are free from plagiarism, Journal of Pharmaceutical Science and Clinical Research (JPSCR) using plagiarism software by Turnitin.com. More detail visit: https://www.turnitin.com/login_page.asp?lang=en_us